Cargando…

Enhanced Efficacy of a Codon-Optimized DNA Vaccine Encoding the Glycoprotein Precursor Gene of Lassa Virus in a Guinea Pig Disease Model When Delivered by Dermal Electroporation

Lassa virus (LASV) causes a severe, often fatal, hemorrhagic fever endemic to West Africa. Presently, there are no FDA-licensed medical countermeasures for this disease. In a pilot study, we constructed a DNA vaccine (pLASV-GPC) that expressed the LASV glycoprotein precursor gene (GPC). This plasmid...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cashman, Kathleen A., Broderick, Kate E., Wilkinson, Eric R., Shaia, Carl I., Bell, Todd M., Shurtleff, Amy C., Spik, Kristin W., Badger, Catherine V., Guttieri, Mary C., Sardesai, Niranjan Y., Schmaljohn, Connie S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2013
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4494234/ https://www.ncbi.nlm.nih.gov/pubmed/26344112 http://dx.doi.org/10.3390/vaccines1030262

Ejemplares similares

A DNA vaccine delivered by dermal electroporation fully protects cynomolgus macaques against Lassa fever
por: Cashman, Kathleen A., et al.
Publicado: (2017)

A multi-head intradermal electroporation device allows for tailored and increased dose DNA vaccine delivery to the skin
por: McCoy, Jay R, et al.
Publicado: (2014)

DNA vaccines elicit durable protective immunity against individual or simultaneous infections with Lassa and Ebola viruses in guinea pigs
por: Cashman, Kathleen A., et al.
Publicado: (2017)

Optimized In Vivo Transfer of Small Interfering RNA Targeting Dermal Tissue Using In Vivo Surface Electroporation
por: Broderick, Kate E, et al.
Publicado: (2012)

Evaluation of Lassa antiviral compound ST-193 in a guinea pig model
por: Cashman, Kathleen A., et al.
Publicado: (2011)

Immunogenicity of a protective intradermal DNA vaccine against lassa virus in cynomolgus macaques
por: Jiang, Jingjing, et al.
Publicado: (2019)

Immune-Mediated Systemic Vasculitis as the Proposed Cause of Sudden-Onset Sensorineural Hearing Loss following Lassa Virus Exposure in Cynomolgus Macaques
por: Cashman, Kathleen A., et al.
Publicado: (2018)

Elucidating the Kinetics of Expression and Immune Cell Infiltration Resulting from Plasmid Gene Delivery Enhanced by Surface Dermal Electroporation
por: Mendoza, Janess M., et al.
Publicado: (2013)

A Lassa Fever Live-Attenuated Vaccine Based on Codon Deoptimization of the Viral Glycoprotein Gene
por: Cai, Yingyun, et al.
Publicado: (2020)

Lassa antiviral LHF-535 protects guinea pigs from lethal challenge
por: Cashman, Kathleen A., et al.
Publicado: (2022)

Development of a New Vaccine for the Prevention of Lassa Fever
por: Geisbert, Thomas W, et al.
Publicado: (2005)

A Fusion-Inhibiting Peptide against Rift Valley Fever Virus Inhibits Multiple, Diverse Viruses
por: Koehler, Jeffrey W., et al.
Publicado: (2013)

Uncoupling GP1 and GP2 expression in the Lassa virus glycoprotein complex: implications for GP1 ectodomain shedding
por: Illick, Megan M, et al.
Publicado: (2008)

Production and Characterization of Human Monoclonal Antibody Fab Fragments to Vaccinia Virus from a Phage-Display Combinatorial Library()
por: Schmaljohn, Connie, et al.
Publicado: (1999)

Enhanced Delivery and Potency of Self-Amplifying mRNA Vaccines by Electroporation in Situ
por: Cu, Yen, et al.
Publicado: (2013)

Ebolavirus Glycoprotein Fc Fusion Protein Protects Guinea Pigs against Lethal Challenge
por: Konduru, Krishnamurthy, et al.
Publicado: (2016)

Households as hotspots of Lassa fever? Assessing the spatial distribution of Lassa virus-infected rodents in rural villages of Guinea
por: Mariën, Joachim, et al.
Publicado: (2020)

Influence of Landscape Patterns on Exposure to Lassa Fever Virus, Guinea
por: Longet, Stephanie, et al.
Publicado: (2023)

Lassa virus glycoprotein: stopping a moving target
por: Hastie, Kathryn M, et al.
Publicado: (2018)

Bacterial-based systems for expression and purification of recombinant Lassa virus proteins of immunological relevance
por: Branco, Luis M, et al.
Publicado: (2008)

Inter-Lineage Variation of Lassa Virus Glycoprotein Epitopes: A Challenge to Lassa Virus Vaccine Development
por: Ibukun, Francis Ifedayo
Publicado: (2020)

Identifying immunodominant multi-epitopes from the envelope glycoprotein of the Lassa mammarenavirus as vaccine candidate for Lassa fever
por: Rowaiye, Adekunle Babajide, et al.
Publicado: (2022)

A Sporadic and Lethal Lassa Fever Case in Forest Guinea, 2019
por: Magassouba, N’Faly, et al.
Publicado: (2020)

Detection of Lassa virus in wild rodent feces: Implications for Lassa fever burden within households in the endemic region of Faranah, Guinea
por: Wood, Rebekah, et al.
Publicado: (2021)

An Outbred Guinea Pig Disease Model for Lassa Fever Using a Host-Adapted Clade III Nigerian Lassa Virus
por: Deschambault, Yvon, et al.
Publicado: (2023)

Structural conservation of Lassa virus glycoproteins and recognition by neutralizing antibodies
por: Perrett, Hailee R., et al.
Publicado: (2023)

Natural History of Aerosol Induced Lassa Fever in Non-Human Primates
por: Downs, Isaac L., et al.
Publicado: (2020)

Spatial and temporal evolution of Lassa virus in the natural host population in Upper Guinea
por: Fichet-Calvet, Elisabeth, et al.
Publicado: (2016)

Hunting and consumption of rodents by children in the Lassa fever endemic area of Faranah, Guinea
por: Douno, Moussa, et al.
Publicado: (2021)

Lassa virus glycoprotein nanoparticles elicit neutralizing antibody responses and protection
por: Brouwer, Philip J.M., et al.
Publicado: (2022)

Adjuvants Differentially Modulate the Immunogenicity of Lassa Virus Glycoprotein Subunits in Mice
por: To, Albert, et al.
Publicado: (2022)

Preconditioning process for dermal tissue decellularization using electroporation with sonication
por: Koo, Min-Ah, et al.
Publicado: (2021)

Case Report: COVID-19 and Lassa Fever Coinfection in an Ebola Suspected Patient in Guinea
por: Keita, Mory, et al.
Publicado: (2022)

Correction: Hunting and consumption of rodents by children in the Lassa fever endemic area of Faranah, Guinea
por: Douno, Moussa, et al.
Publicado: (2023)

Identification of Residues in Lassa Virus Glycoprotein Subunit 2 That Are Critical for Protein Function
por: Willard, Katherine A., et al.
Publicado: (2018)

Lassa virus glycoprotein complex review: insights into its unique fusion machinery
por: Pennington, Hallie N., et al.
Publicado: (2022)

A Recombinant Vesicular Stomatitis Virus-Based Lassa Fever Vaccine Protects Guinea Pigs and Macaques against Challenge with Geographically and Genetically Distinct Lassa Viruses
por: Safronetz, David, et al.
Publicado: (2015)

A recombinant vesicular stomatitis-based Lassa fever vaccine elicits rapid and long-term protection from lethal Lassa virus infection in guinea pigs
por: Stein, Derek R., et al.
Publicado: (2019)

Lassa virus-like particles displaying all major immunological determinants as a vaccine candidate for Lassa hemorrhagic fever
por: Branco, Luis M, et al.
Publicado: (2010)

Lassa Virus Targeting of Anterior Uvea and Endothelium of Cornea and Conjunctiva in Eye of Guinea Pig Model
por: Gary, Joy M., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_cceifi1lrc08jdd1qstj84m2hj